BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)
TheFly reported on January 8, 2026, that BofA reduced the price target for Hims & Hers Health, Inc. (NYSE:HIMS) to $29 from $32. It retained an Underperform rating on the stock.







